Literature DB >> 21798219

NKG2D and its ligands: key to immunotherapy of liver cancer?

Mario U Mondelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21798219     DOI： 10.1016/j.jhep.2011.07.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  Immunological landscape and immunotherapy of hepatocellular carcinoma.

Authors:  Jesús Prieto; Ignacio Melero; Bruno Sangro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 46.802

Review 2.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

3.  Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity.

Authors:  D Min; X-b Lv; X Wang; B Zhang; W Meng; F Yu; H Hu
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

4.  Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.

Authors:  Guo-Tian Ruan; Hai-Lun Xie; Li-Chen Zhu; Yi-Zhong Ge; Lin Yan; Cun Liao; Yi-Zhen Gong; Han-Ping Shi
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.